The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Festal Plus
Cellulase AP3 , Pancreatin, Simethicone · PANCRELIPASE 315 mg/1; DIMETHICONE 30 mg/1 · Tablet · Oral · Lydia Co., Ltd.
NDC 72988-0038-01 · 10 TABLET in 1 PACKAGE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cellulase AP3 , Pancreatin, Simethicone (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lydia Co., Ltd. | PANCRELIPASE 315 mg/1; DIMETHICONE 30 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lydia Co., Ltd. | PANCRELIPASE 30 mg/1; DIMETHICONE 315 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Lydia Co., Ltd. | DIMETHICONE 30 mg/1; PANCRELIPASE 315 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Festal Plus — NDC 72988-0038-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72988003801.
Free to cite with attribution — see how the data is put together.